Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells medicines in mainland China, founded in 1995 in Lianyungang, Jiangsu Province, by Zhong Huijuan, who remains the company's chair. Described as the largest psychotropic drug producer in China, the company completed its initial public offering on the Hong Kong Stock Exchange on June 14, 2019, and was added to the Hang Seng Index in August 2022. This description is adapted from Wikipedia contributors under CC BY-SA 4.0; changes were made. https://creativecommons.org/licenses/by-sa/4.0/